Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Bergh

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Expert Opinion on Medical Diagnostics|March 15, 2013
Tumor indicating normal tissue could be a new source of diagnostic and prognostic markers for prostate cancerSofia Halin, Peter Hammarsten, Hani Adamo, et al.
The Journal of Urology|July 20, 2002
Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resectionLars Egevad, Torvald Granfors, Lars Karlberg, et al.
Oncogene|February 2, 2019
PKCζ facilitates lymphatic metastatic spread of prostate cancer cells in a mice xenograft modelGuangxiang Zang, Yabing Mu, Linlin Gao, et al.
Spine|June 1, 2012
Predicting survival for surgery of metastatic spinal cord compression in prostate cancer: a new scoreSead Crnalic, Richard Löfvenberg, Anders Bergh, et al.
Frontiers in Molecular Biosciences|April 22, 2025
Metabolic readouts of tumor instructed normal tissues (TINT) identify aggressive prostate cancer subgroups for tailored therapyIlona Dudka, João Figueira, Pernilla Wikström, et al.
Medical & Biological Engineering & Computing|November 10, 2006
Prostate cancer detection with an improved resonance sensor system: parameter evaluation in a silicone model and on human prostate tissue in vitroPeter Lindberg, Britt Andersson, Anders Bergh, et al.
International Journal of Cancer|October 23, 2004
Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective studyJohan Hultdin, Bethany Van Guelpen, Anders Bergh, et al.
The Prostate|May 3, 2002
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancerPernilla Wikström, Ingela Franck Lissbrant, Pär Stattin, et al.
Human Gene Therapy|February 10, 2009
Replication-competent Ad11p vector (RCAd11p) efficiently transduces and replicates in hormone-refractory metastatic prostate cancer cellsLinda Sandberg, Praveen Papareddy, Jim Silver, et al.
The Prostate|September 8, 2017
Reduced number of CD169<sup>+</sup> macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patientsKerstin Strömvall, Kristoffer Sundkvist, Börje Ljungberg, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Expert Opinion on Medical Diagnostics|March 15, 2013
Tumor indicating normal tissue could be a new source of diagnostic and prognostic markers for prostate cancerSofia Halin, Peter Hammarsten, Hani Adamo, et al.
The Journal of Urology|July 20, 2002
Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resectionLars Egevad, Torvald Granfors, Lars Karlberg, et al.
Oncogene|February 2, 2019
PKCζ facilitates lymphatic metastatic spread of prostate cancer cells in a mice xenograft modelGuangxiang Zang, Yabing Mu, Linlin Gao, et al.
Spine|June 1, 2012
Predicting survival for surgery of metastatic spinal cord compression in prostate cancer: a new scoreSead Crnalic, Richard Löfvenberg, Anders Bergh, et al.
Frontiers in Molecular Biosciences|April 22, 2025
Metabolic readouts of tumor instructed normal tissues (TINT) identify aggressive prostate cancer subgroups for tailored therapyIlona Dudka, João Figueira, Pernilla Wikström, et al.
Medical & Biological Engineering & Computing|November 10, 2006
Prostate cancer detection with an improved resonance sensor system: parameter evaluation in a silicone model and on human prostate tissue in vitroPeter Lindberg, Britt Andersson, Anders Bergh, et al.
International Journal of Cancer|October 23, 2004
Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective studyJohan Hultdin, Bethany Van Guelpen, Anders Bergh, et al.
The Prostate|May 3, 2002
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancerPernilla Wikström, Ingela Franck Lissbrant, Pär Stattin, et al.
Human Gene Therapy|February 10, 2009
Replication-competent Ad11p vector (RCAd11p) efficiently transduces and replicates in hormone-refractory metastatic prostate cancer cellsLinda Sandberg, Praveen Papareddy, Jim Silver, et al.
The Prostate|September 8, 2017
Reduced number of CD169<sup>+</sup> macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patientsKerstin Strömvall, Kristoffer Sundkvist, Börje Ljungberg, et al.
Pageof 19